Drug Combination Details
General Information of the Combination (ID: C52995) | |||||
---|---|---|---|---|---|
Name | Anidulafungin NP Info | + | Voriconazole Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Aspergillosis
[ICD-11: 1F20]
|
Phase 3 | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [2] | |||||
Molecule(s)
Regulation |
Up-regulation | Expression | CYP51A1 | Molecule Info |
Pathway MAP
|
|
In-vitro Model | Aspergillus fumigatus | Microorganism model | Aspergillus fumigatus | |||
Experimental
Result(s) |
The combination demonstrated synergy against the VCZ-R clinical isolate as well. |
